245 related articles for article (PubMed ID: 38319453)
1. Clusterin: a marker and mediator of chemoresistance in colorectal cancer.
Hlavca S; Chan WH; Engel RM; Abud HE
Cancer Metastasis Rev; 2024 Mar; 43(1):379-391. PubMed ID: 38319453
[TBL] [Abstract][Full Text] [Related]
2. Patient-Derived Colorectal Cancer Organoids Upregulate Revival Stem Cell Marker Genes following Chemotherapeutic Treatment.
Engel RM; Chan WH; Nickless D; Hlavca S; Richards E; Kerr G; Oliva K; McMurrick PJ; Jardé T; Abud HE
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31906589
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle heterogeneity and plasticity of colorectal cancer stem cells.
Higa T; Nakayama KI
Cancer Sci; 2024 May; 115(5):1370-1377. PubMed ID: 38413370
[TBL] [Abstract][Full Text] [Related]
4. Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis.
Shapiro B; Tocci P; Haase G; Gavert N; Ben-Ze'ev A
Oncotarget; 2015 Oct; 6(33):34389-401. PubMed ID: 26399194
[TBL] [Abstract][Full Text] [Related]
5. Single-cell transcriptomes of the regenerating intestine reveal a revival stem cell.
Ayyaz A; Kumar S; Sangiorgi B; Ghoshal B; Gosio J; Ouladan S; Fink M; Barutcu S; Trcka D; Shen J; Chan K; Wrana JL; Gregorieff A
Nature; 2019 May; 569(7754):121-125. PubMed ID: 31019301
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the Role of Intestinal Crypt Cell Populations in Resistance to Chemotherapy.
Frau C; Jamard C; Delpouve G; Guardia GDA; Machon C; Pilati C; Nevé CL; Laurent-Puig P; Guitton J; Galante PAF; Penalva LO; Freund JN; de la Fouchardiere C; Plateroti M
Cancer Res; 2021 May; 81(10):2730-2744. PubMed ID: 33741693
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells.
Kemper K; Prasetyanti PR; De Lau W; Rodermond H; Clevers H; Medema JP
Stem Cells; 2012 Nov; 30(11):2378-86. PubMed ID: 22969042
[TBL] [Abstract][Full Text] [Related]
8. High clusterin (CLU) mRNA expression levels in tumors of colorectal cancer patients predict a poor prognostic outcome.
Artemaki PI; Sklirou AD; Kontos CK; Liosi AA; Gianniou DD; Papadopoulos IN; Trougakos IP; Scorilas A
Clin Biochem; 2020 Jan; 75():62-69. PubMed ID: 31672651
[TBL] [Abstract][Full Text] [Related]
9. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
[TBL] [Abstract][Full Text] [Related]
11. Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer.
Wei L; Xue T; Wang J; Chen B; Lei Y; Huang Y; Wang H; Xin X
Int J Cancer; 2009 Aug; 125(4):791-806. PubMed ID: 19391138
[TBL] [Abstract][Full Text] [Related]
12. GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism.
Zhang S; Chatterjee T; Godoy C; Wu L; Liu QJ; Carmon KS
Mol Cancer Res; 2019 Nov; 17(11):2196-2207. PubMed ID: 31444231
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of clusterin alters mitochondrial dynamics, facilitates necrosis in camptothecin-induced cancer stem cells.
Arumugam P; Samson A; Ki J; Song JM
Cell Biol Toxicol; 2017 Jun; 33(3):307-321. PubMed ID: 28064403
[TBL] [Abstract][Full Text] [Related]
14. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
15. A pre-existing population of ZEB2
Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
[TBL] [Abstract][Full Text] [Related]
16. Visualization and targeting of LGR5
Shimokawa M; Ohta Y; Nishikori S; Matano M; Takano A; Fujii M; Date S; Sugimoto S; Kanai T; Sato T
Nature; 2017 May; 545(7653):187-192. PubMed ID: 28355176
[TBL] [Abstract][Full Text] [Related]
17. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum.
Takahashi H; Ishii H; Nishida N; Takemasa I; Mizushima T; Ikeda M; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2011 Apr; 18(4):1166-74. PubMed ID: 21125339
[TBL] [Abstract][Full Text] [Related]
18. F-Box/WD Repeat Domain-Containing 7 Induces Chemotherapy Resistance in Colorectal Cancer Stem Cells.
Honma S; Hisamori S; Nishiuchi A; Itatani Y; Obama K; Shimono Y; Sakai Y
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31067777
[TBL] [Abstract][Full Text] [Related]
19. Plastic persisters: revival stem cells in colorectal cancer.
Tape CJ
Trends Cancer; 2024 Mar; 10(3):185-195. PubMed ID: 38071119
[TBL] [Abstract][Full Text] [Related]
20. CLU (clusterin) promotes mitophagic degradation of MSX2 through an AKT-DNM1L/Drp1 axis to maintain SOX2-mediated stemness in oral cancer stem cells.
Praharaj PP; Patra S; Mishra SR; Mukhopadhyay S; Klionsky DJ; Patil S; Bhutia SK
Autophagy; 2023 Aug; 19(8):2196-2216. PubMed ID: 36779631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
